Αρχική World News Study Shows That Fast-Mimicking Diets Are Safe and Effective for Patients Undergoing...

Study Shows That Fast-Mimicking Diets Are Safe and Effective for Patients Undergoing Chemo

Diet is important to anyone’s health, but it’s particularly vital for people who are ill. If you have cancer and are undergoing chemotherapy, you may be wondering whether popular diets such as intermittent fasting can be good for you.In many cases, not enough research has been done to determine whether current fad diets can be safe and effective for chemo patients. But we’re learning more about health and wellness for cancer patients every day! One new study showcases a particular diet that may be the way to go for some patients—fast-mimicking diets.Juice detoxes, water fasting, and soup diets are sometimes used to stimulate healthy weight loss and cleanse toxins from the body. Since chemotherapy patients are often looking for ways to help their bodies recover from the toxins in chemotherapy drugs, these diets may seem like good options. So researchers set out to find out how safe fast-mimicking diets are for people undergoing chemo—and whether they actually help.Photo: Adobe Stock/MultiartFast-mimicking diets are plant-based diets generally consisting of soups, broths, tea, and other liquids. Cancer thrives on carbohydrates and red meat, so removing those items from the diet restricts the cancer cells’ ability to grow and multiply.In a preclinical trial, Dr. Judith Kroep and her colleagues kept tabs on 129 “relatively fit” patients with HER2-negative stage II/III breast cancer as they followed either their regular diet or a fast-mimicking diet for three days prior to undergoing neoadjuvant chemotherapy in the hopes of shrinking cancerous tumors before surgery. The macronutrient ratios and amounts of the fast-mimicking diet were the same for each participant, and a micronutrient supplement was added.Photo: Adobe Stock/M.studioNo difference in toxicity was observed between the two groups, but the researchers did observe better tumor control following chemotherapy in the fast-mimicking group. The diet appeared to do a better job of protecting healthy cells and making cancer cells more susceptible to treatment.Roughly 80 to 85 percent of breast cancer patients have the HER2-negative variety, but Dr. Kroep says that animal studies suggest this type of diet may be useful to patients with other types of cancers too. However, it is quite possible that cancer patients who are less physically fit or who suffer from cachexia (unhealthy weight loss due to severe illness, such as metastatic cancer) may not fare as well.Photo: Adobe Stock/Pixel-ShotOverall, though, it appears that short-term fasting and fast-mimicking diets are likely safe and effective for chemotherapy patients and may be useful as part of a more comprehensive treatment plan. They appear to help protect healthy cells against chemotherapy while also making cancer cells more vulnerable to treatment.“This study is a stepping stone in cancer dietary management. More studies are needed to confirm our finding and extend them to other cancer types,” says Kroep. “We plan to do some of that work.”Please always consult your doctor before starting a new diet, especially one as extreme as fat-mimicking or fasting. But we’re excited that cancer patients may now have one more tool in their arsenal. Stay healthy, friends!Source

NEWSLETTER

Συμπληρώστε το email σας για να λαμβάνετε τις σημαντικότερες ειδήσεις από το ogkologos.com

Βρείτε μας

2,449ΥποστηρικτέςΚάντε Like
57ΑκόλουθοιΑκολουθήστε

Διαβαστε Επίσης

Καρκίνος και Κορωνοϊός (COVID-19) ΜΕΡΟΣ Α

Εάν είστε καρκινοπαθής, το ανοσοποιητικό σας σύστημα μπορεί να μην είναι τόσο ισχυρό όσο κανονικά, έτσι μπορεί να ανησυχείτε για τους κινδύνους που σχετίζονται...

ΠΑΓΚΟΣΜΙΑ ΗΜΕΡΑ ΚΑΡΚΙΝΟΥ

Η Παγκόσμια Ημέρα Κατά του Καρκίνου καθιερώθηκε με πρωτοβουλία της Διεθνούς Ένωσης κατά του Καρκίνου (UICC), που εκπροσωπεί 800 οργανώσεις σε 155 χώρες του...

ΕΞΕΛΙΞΕΙΣ ΣΤΗ ΘΕΡΑΠΕΙΑ ΤΟΥ ΜΗ-ΜΙΚΡΟΚΥΤΤΑΡΙΚΟΥ ΚΑΡΚΙΝΟΥ ΤΟΥ ΠΝΕΥΜΟΝΑ (ΜΜΚΠ)

ΕΞΕΛΙΞΕΙΣ ΣΤΗ ΘΕΡΑΠΕΙΑ ΤΟΥ ΜΗ-ΜΙΚΡΟΚΥΤΤΑΡΙΚΟΥ ΚΑΡΚΙΝΟΥ ΤΟΥ ΠΝΕΥΜΟΝΑ (ΜΜΚΠ) Γράφει ο Δρ Παπαδούρης Σάββας, Παθόλογος-Ογκολόγος   Ο ΜΜΚΠ βρίσκεται αναλογικά στο 80% και πλέον του συνολικού...

Διατρέχουν όντως οι καρκινοπαθείς μεγαλύτερο κίνδυνο λόγω κοροναϊού;

Σε πρακτικό επίπεδο, τα δεδομένα των σχετικών μελετών υποδηλώνουν ότι η χημειοθεραπεία ή οι άλλες αντι-νεοπλασματικές θεραπείες δεν αυξάνουν σημαντικά τον κίνδυνο θνησιμότητας από...

FDA: Η ακτινοβολία των smartphones δεν προκαλεί καρκίνο

Σε μια νέα έκθεσή της, η Υπηρεσία Τροφίμων και Φαρμάκων (FDA) των ΗΠΑ αναφέρει ότι επανεξέτασε τις σχετικές επιστημονικές έρευνες που δημοσιεύθηκαν τα τελευταία...

Νέα ανακάλυψη, νέα ελπίδα για τον καρκίνο

Ένα νεοανακαλυφθέν τμήμα του ανοσοποιητικού μας συστήματος θα μπορούσε να αξιοποιηθεί για την αντιμετώπιση όλων των ειδών καρκίνου, σύμφωνα με επιστήμονες του πανεπιστημίου Cardiff...
- Advertisment -

Ροή Ειδήσεων

Avapritinib Not Superior to Regorafenib in Terms of Median PFS in Third-Line or Later Treatment of Patients with Unresectable or Metastatic GIST

Findings from an open-label, randomised, multicentre phase III VOYAGER study indicate that avapritinib is not superior to regorafenib in terms of median progression-free survival...

Patients less likely to rate cancer care as ‘very good’ during pandemic

Almost a third of cancer patients have reported receiving worse care since COVID-19 began, according to a new survey commissioned by Cancer Research UK. Whilst...

How to Avoid Spreading Harmful Chemo Chemicals to Members of Your Household

Cancer is not contagious, and neither is chemotherapy. However, harmful chemotherapy drugs can sometimes still be present in the bodily fluids of a person...

Can’t Sleep? Tips for Coping with Insomnia

Insomnia* is common for cancer patients**, as well as for the general population. We frequently hear from our patients and their caregivers that sleeping through the night...

New Task Force Focuses on Quality of Life for AYAs with Cancer

August 4, 2021, by NCI Staff Adolescents and young adults are using mobile devices to document the impact of cancer and its treatment on their...

Amivantamab Demonstrates Robust Efficacy in Patients with EGFR Exon 20 Insertion-Mutated NSCLC

Amivantamab demonstrated robust and durable responses in patients with epidermal growth factor receptor Exon 20 insertion (EGFR Exon20ins)-mutated non-small cell lung cancer (NSCLC) after progression on...